Posted on

Young Man Becomes First in World to Be Cured of FSGS With New Treatment

Loading

Combined stem cell transplant and kidney transplant prove a winning combination against autoimmune FSGS

Imagine spending a good share of your childhood hooked up to a machine. While your friends are traveling on a bus to a school game or hanging out at the mall, you are at home or at a dialysis center tethered by cords, every day for at least three hours. A lot of kids would give up trying to keep up with life. Not 21-year-old Traejen Kingston. 
Read the full story from Stanford Children’s Health.

Loading
Posted on

Donor socioeconomic status affects hematopoietic stem cell transplant outcomes

Loading

SALT LAKE CITY — Socioeconomic disadvantage among hematopoietic stem cell transplant donors appeared associated with poorer outcomes among transplant recipients, according to study results.

The findings — presented at Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR — indicate a biologic impact of socioeconomic status on hematopoietic cells that is transferrable from HSCT donor to recipient, researchers concluded. Read more in Healio.

Loading
Posted on

Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant

Loading

Front Oncol. 2022 Feb 25;12:801879. doi: 10.3389/fonc.2022.801879. eCollection 2022.

ABSTRACT

BACKGROUND: Allogeneic hematopoietic stem cell transplant (allo-HCT) is a potential curative therapy for a variety of hematologic disorders. However, it requires highly specialized care that is only available at select centers across the country. Thus, minority populations are at risk for healthcare disparities in access to and outcomes of allo-HCT. Our study aimed to assess the impact of race and location of residence on outcomes of allo-HCT. Read more.

Loading
Posted on

Researchers report third case of HIV remission after stem cell transplant using umbilical cord blood

Loading

(CNN)A US woman has become the third known person who’s gone into HIV remission, and the first mixed-race woman, thanks to a transplant of stem cells from umbilical cord blood, according to research presented at a conference Tuesday.

The woman, whom the researchers described as middle-aged and of mixed race, was diagnosed with acute myeloid leukemia four years after an HIV diagnosis, according to an abstract from the Conference on Retroviruses and Opportunistic Infections.
Read the full story.

Loading
Posted on

A Twist on Stem Cell Transplants Could Help Blood Cancer Patients

Loading

CATHY DOYLE FELT fine. And in April 2016, when she logged in to a web portal to check the results of some routine blood work, the little numbers on the screen agreed—mostly. But her white blood cell count looked low. She called the doctor’s office. “What’s going on?” the chatty, spiritual 58-year-old from Pittsburgh remembers saying.

The staff asked if she’d recently been sick. She had. Doyle caught a bad cough on a family cruise, but it had passed. That might be it, they agreed, but it would be best to come in for more blood tests. “Bless the doctor,” Doyle says. “He just kept hoping it wouldn’t be leukemia.” Read more here.

Loading